CM
IRMD icon

Castleark Management’s iRadimed IRMD Stock Holding History

Castleark Management’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-224,550
Closed -$4.3M – 384
2016
Q1 		$4.3M Buy
224,550
+49,550
+28% +$948K 0.13% 193
2015
Q4 		$4.91M Buy
+175,000
New +$4.95M 0.15% 164

Other funds holding IRMD

CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JWA
JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
MCM
McKinley Capital Management Anchorage, Alaska $571M AUM 36.44% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
TCM
Timpani Capital Management Milwaukee, Wisconsin $209M AUM 62.15% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Castleark Management's IRMD Position: Q2 2016 in Review

Castleark Management sold out of iRadimed (IRMD) in Q2 2016, closing a stake of 224,550 shares — an estimated $4.3M sold.

Castleark Management first reported a position in IRMD in Q4 2015 and held it in 2 quarters. The position peaked at $4.91M in Q4 2015. 60 funds tracked by Wall St. Rank hold IRMD as of Q2 2016.

  • Castleark Management reported no remaining iRadimed position as of Q2 2016 after selling out during the quarter.
  • Castleark Management sold 224,550 iRadimed shares in Q2 2016, an estimated $4.3M.
  • Castleark Management first reported a position in iRadimed in Q4 2015 and held it in 2 quarters.
  • Castleark Management's iRadimed position peaked at $4.91M in Q4 2015.
  • 60 funds tracked by Wall St. Rank held iRadimed as of Q2 2016.

Based on Castleark Management's 13F filing for Q2 2016, filed 10 Aug 2016.